Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure
Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase react...
Saved in:
Published in | Scientific reports Vol. 9; no. 1; p. 1457 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
06.02.2019
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 2045-2322 2045-2322 |
DOI | 10.1038/s41598-018-37837-4 |
Cover
Abstract | Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after
im
administration of a single dose of 0.1 LD
50
, 0.5 LD
50
, and 1.0 LD
50
of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD
50
of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD
50
of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD
50
and 1.0 LD
50
of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation. |
---|---|
AbstractList | Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after
im
administration of a single dose of 0.1 LD
50
, 0.5 LD
50
, and 1.0 LD
50
of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD
50
of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD
50
of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD
50
and 1.0 LD
50
of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation. Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation. Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD , 0.5 LD , and 1.0 LD of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD and 1.0 LD of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation. Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation.Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated which morphological changes could be observed in Wistar rats after the treatment with increasing doses of selected acetyl cholinesterase reactivators - asoxime, obidoxime, K027, K048, and K075. Subsequently, heart, diaphragm and musculus popliteus were obtained for pathohistological and semiquantitative analysis 24 hrs and 7 days after im administration of a single dose of 0.1 LD50, 0.5 LD50, and 1.0 LD50 of each oxime. Different muscle damage score was based on an estimation scale from 0 (no damage) to 5 (strong damage). In rats treated with 0.1 LD50 of each oxime, muscle fibres did not show any change. The intensive degeneration was found in all muscles after treatment with 0.5 LD50 of asoxime and obidoxime, respectively. Acute toxic muscle injury was developed within 7 days following treatment with 0.5 LD50 and 1.0 LD50 of each oxime, with the highest values in K048 and K075 group (P < 0.001 vs. control and asoxime), respectively. The early muscle alterations observed in our study seem to contribute to the pathogenesis of the oxime-induced toxic muscle injury, which probably manifests as necrosis and/or inflammation. |
ArticleNumber | 1457 |
Author | Nepovimova, Eugenie Jaćević, Vesna Kuča, Kamil |
Author_xml | – sequence: 1 givenname: Vesna orcidid: 0000-0001-5137-2638 surname: Jaćević fullname: Jaćević, Vesna organization: National Poison Control Centre, Military Medical Academy, Faculty of Medicine of the Military Medical Academy, University of Defence, Department of Chemistry, Faculty of Science, University of Hradec Kralove – sequence: 2 givenname: Eugenie surname: Nepovimova fullname: Nepovimova, Eugenie organization: Department of Chemistry, Faculty of Science, University of Hradec Kralove – sequence: 3 givenname: Kamil surname: Kuča fullname: Kuča, Kamil email: kamil.kuca@uhk.cz organization: Department of Chemistry, Faculty of Science, University of Hradec Kralove |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30728420$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtvGyEUhVGVqHn-gS4qpG66mZbXDLCpFEVOGilVpMhZI8B3XKwxuDC0zr_vpE7TNIuwAYnvHM7lHKG9mCIg9I6ST5Rw9bkI2mrVEKoaLhWXjXiDDhkRbcM4Y3vPzgfotJQVmVbLtKD6LTrgRDIlGDlEs3naBo-v4qrmezwm_K0WPwCeh1Iq4NTjWzsWfJGGIf0KcYnPfB0B32zDGgqebTep1AwnaL-3Q4HTx_0Y3V3M5udfm-uby6vzs-vGCynGhi9cb50WDByTDkBq2XFCbcvAd9S1xLXacW-9XmjXS9FTpV0HoBaeeWU7foy-7Hw31a1h4SGO2Q5mk8Pa5nuTbDD_38Tw3SzTT9Pxrm2ZnAw-Phrk9KNCGc06FA_DYCOkWgxjTBOpKFUT-uEFuko1x2k8w6jsJOkkJxP1_nmipyh_f3gC2A7wOZWSoX9CKDEPTZpdk2Zq0vxp0ohJpF6IfBjtGNLDVGF4Xcp30jK9E5eQ_8V-RfUbRzqynw |
CitedBy_id | crossref_primary_10_3390_ijms23052596 crossref_primary_10_1016_j_etap_2019_103221 crossref_primary_10_1007_s00204_021_03098_w crossref_primary_10_1016_j_cbi_2019_05_035 crossref_primary_10_1039_D3RA00717K crossref_primary_10_1016_j_biopha_2023_115600 crossref_primary_10_1016_j_fct_2020_111138 crossref_primary_10_1002_adma_202101326 crossref_primary_10_3390_toxins12100643 crossref_primary_10_1016_j_cbi_2023_110658 crossref_primary_10_2174_1874104502015010017 crossref_primary_10_2174_0929867330999221014104610 crossref_primary_10_1155_2020_1720961 crossref_primary_10_1016_j_cbi_2024_111138 crossref_primary_10_1038_s41598_019_52768_4 crossref_primary_10_1186_s43141_022_00429_x crossref_primary_10_3390_ijms21197236 |
Cites_doi | 10.1038/nm.3869 10.1016/S0960-894X(03)00751-0 10.1113/jphysiol.2006.118265 10.1016/j.cbi.2016.04.034 10.1016/j.coph.2006.01.006 10.1039/C6TX00130K 10.2174/092986709788803088 10.1016/j.toxlet.2011.04.004 10.1016/j.yrtph.2014.12.019 10.1111/j.1742-7843.2008.00249.x 10.1080/01480540601017637 10.1016/j.imbio.2013.09.001 10.1016/j.tcb.2005.10.007 10.1186/s40360-017-0193-y 10.1590/1414-431X20165646 10.1177/0885066603258659 10.1016/j.tox.2005.06.011 10.1007/s00204-016-1827-3 10.1016/S0065-2423(04)38006-6 10.1007/s002040050100 10.1136/bjsm.37.4.284 10.1038/s41598-018-32376-4 10.1096/fj.14-270090 10.1016/j.cbi.2012.08.019 10.1002/jat.1457 10.1007/BF03033319 10.1515/aiht-2015-66-2623 10.1016/j.neuro.2016.05.006 10.3121/cmr.2007.701 10.1016/j.jab.2016.05.004 10.1016/j.toxlet.2011.04.006 10.1016/j.cbi.2012.08.014 10.3390/ijms19082370 10.1097/BOR.0000000000000108 10.1242/dev.069088 10.1023/A:1024960819430 10.1016/j.toxlet.2009.07.025 10.2174/1568026611209061775 10.1016/j.tem.2015.07.005 10.1152/ajpregu.00454.2004 10.1002/jat.1084 10.1016/S0040-4039(03)00538-0 10.1016/j.yexmp.2017.03.005 10.1016/j.tox.2005.11.003 10.1021/jm070653r 10.1016/j.tiv.2006.06.009 10.1016/j.biopha.2010.01.002 10.1084/jem.20070075 10.3390/ijms140816882 10.1038/mt.2015.97 10.1016/j.yrtph.2016.07.011 10.1002/jat.1229 10.1186/s40634-016-0051-7 10.2174/1389557514666140219103138 10.1249/00005768-199507000-00011 10.1093/chromsci/46.4.316 10.14429/dlsj.1.10733 10.1016/j.cbi.2012.10.017 10.1093/toxsci/kfp166 10.1038/nrneph.2014.133 10.1083/jcb.200212046 10.1242/dev.067587 10.1007/s00204-012-0977-1 10.1080/00032710701588531 10.1023/A:1015818821686 10.1016/S0889-857X(21)00069-7 10.1002/cphy.c100092 10.33549/physiolres.932105 10.21236/ADA398241 10.1007/978-3-0348-8958-2_19 |
ContentType | Journal Article |
Copyright | The Author(s) 2019 This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
Copyright_xml | – notice: The Author(s) 2019 – notice: This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
DBID | C6C AAYXX CITATION NPM 3V. 7X7 7XB 88A 88E 88I 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M2P M7P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI Q9U 7X8 5PM |
DOI | 10.1038/s41598-018-37837-4 |
DatabaseName | Springer Nature OA Free Journals CrossRef PubMed ProQuest Central (Corporate) Health & Medical Collection ProQuest Central (purchase pre-March 2016) Biology Database (Alumni Edition) Medical Database (Alumni Edition) Science Database (Alumni Edition) ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One ProQuest Central Korea Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) ProQuest Biological Science Collection Health & Medical Collection (Alumni) Medical Database Science Database Biological Science Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central Basic MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed Publicly Available Content Database ProQuest Central Student ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Biology Journals (Alumni Edition) ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Science Journals (Alumni Edition) ProQuest Biological Science Collection ProQuest Central Basic ProQuest Science Journals ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef Publicly Available Content Database PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
EISSN | 2045-2322 |
ExternalDocumentID | PMC6365527 30728420 10_1038_s41598_018_37837_4 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | 0R~ 3V. 4.4 53G 5VS 7X7 88A 88E 88I 8FE 8FH 8FI 8FJ AAFWJ AAJSJ AAKDD ABDBF ABUWG ACGFS ACSMW ACUHS ADBBV ADRAZ AENEX AEUYN AFKRA AJTQC ALIPV ALMA_UNASSIGNED_HOLDINGS AOIJS AZQEC BAWUL BBNVY BCNDV BENPR BHPHI BPHCQ BVXVI C6C CCPQU DIK DWQXO EBD EBLON EBS EJD ESX FYUFA GNUQQ GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE KQ8 LK8 M0L M1P M2P M48 M7P M~E NAO OK1 PIMPY PQQKQ PROAC PSQYO RNT RNTTT RPM SNYQT UKHRP AASML AAYXX AFPKN CITATION PHGZM PHGZT NPM 7XB 8FK K9. PJZUB PKEHL PPXIY PQEST PQGLB PQUKI PUEGO Q9U 7X8 5PM |
ID | FETCH-LOGICAL-c474t-3dbfab942eb27bee7976301a52ec61b50b59b3cac9d9bf74f189b6ee8dc2c8a63 |
IEDL.DBID | M48 |
ISSN | 2045-2322 |
IngestDate | Thu Aug 21 18:20:44 EDT 2025 Fri Sep 05 08:57:38 EDT 2025 Tue Sep 09 14:51:37 EDT 2025 Thu Jan 02 22:58:36 EST 2025 Thu Apr 24 23:01:39 EDT 2025 Tue Jul 01 00:58:31 EDT 2025 Fri Feb 21 02:40:51 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c474t-3dbfab942eb27bee7976301a52ec61b50b59b3cac9d9bf74f189b6ee8dc2c8a63 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0001-5137-2638 |
OpenAccessLink | https://www.proquest.com/docview/2176706730?pq-origsite=%requestingapplication% |
PMID | 30728420 |
PQID | 2176706730 |
PQPubID | 2041939 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6365527 proquest_miscellaneous_2229078118 proquest_journals_2176706730 pubmed_primary_30728420 crossref_primary_10_1038_s41598_018_37837_4 crossref_citationtrail_10_1038_s41598_018_37837_4 springer_journals_10_1038_s41598_018_37837_4 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-02-06 |
PublicationDateYYYYMMDD | 2019-02-06 |
PublicationDate_xml | – month: 02 year: 2019 text: 2019-02-06 day: 06 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Scientific reports |
PublicationTitleAbbrev | Sci Rep |
PublicationTitleAlternate | Sci Rep |
PublicationYear | 2019 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Bajgar (CR8) 2009; 16 Schlager, Dolzine, Stewart, Wannarka, Shih (CR18) 1991; 8 Andrade (CR36) 2016; 49 Bohlmeyer, Wu, Perryman (CR50) 1994; 20 Sharma (CR21) 2016; 259 Jones, Kirsch, Wortmann, Pillinger (CR47) 2014; 26 Tidball (CR54) 2005; 288 Kuca, Bielavsky, Cabal, Kassa (CR71) 2003; 13 CR37 Jaćević (CR76) 2016; 14 CR35 Chambers, Chambers, Meek, Pringle (CR22) 2013; 203 Soukup, Jun, Tobin, Kuca (CR31) 2013; 87 Kuca, Bielavsky, Cabal, Bielavska (CR70) 2003; 44 Munoz-Canoves, Serrano (CR64) 2015; 26 Tidball (CR55) 1995; 27 Vassallo (CR45) 2009; 111 Bartosova, Kuca, Kunesova, Jun (CR33) 2006; 9 Lorke (CR28) 2007; 27 Pejchal (CR44) 2008; 103 Tidball (CR53) 2011; 1 Tidball, Wehling-Henricks (CR57) 2007; 578 Swami, Saxena, Karade, Kumar (CR38) 2016; 1 Moshiri (CR48) 2017; 20 Szinicz (CR1) 2005; 214 Sambasivan (CR67) 2011; 138 CR2 Jokanovic (CR11) 2009; 190 Bajgar (CR7) 2004; 38 Litchfield, Wilcoxon (CR75) 1949; 96 CR5 de Koning, van Grol, Noort (CR25) 2011; 206 Garattini, Perico (CR26) 2014; 10 Toumi, Best (CR56) 2003; 37 Jokanovic (CR12) 2012; 12 CR49 Masson (CR9) 2011; 206 Adamson (CR39) 2016; 80 CR46 Zhao (CR61) 2016; 30 Nežić (CR79) 2018; 8 Soukup (CR29) 2010; 64 Antonijevic (CR34) 2016; 55 Žunec (CR43) 2015; 66 Musilek (CR40) 2007; 50 Sorichter, Puschendorf, Mair (CR51) 1999; 5 McLennan (CR59) 1996; 188 Gorecki (CR14) 2016; 90 Antonijevic, Stojiljkovic (CR4) 2007; 5 Spöhrer, Thiermann, Klimmek, Eyer (CR17) 1994; 68 Sepsova (CR27) 2014; 14 Wang (CR41) 2015; 71 Sakurada (CR15) 2003; 28 Jun (CR73) 2007; 40 Radic (CR23) 2013; 203 Kovarik (CR24) 2013; 203 Arnold (CR60) 2007; 204 Kuca (CR72) 2005; 25 Kuca, Jun, Bajgar (CR13) 2007; 30 Tidball, Welc (CR58) 2015; 23 Lorke, Petroianu (CR16) 2009; 29 Chazaud (CR62) 2014; 219 Lemos (CR65) 2015; 21 Jaćević (CR77) 2017; 102 Jaćević (CR78) 2018; 19 Kuča (CR42) 2018; 19 Wiener, Hoffman (CR6) 2004; 19 Dalton (CR10) 2006; 20 Nepovimova (CR20) 2016; 5 Laumonier, Menetrey (CR52) 2016; 3 Korabecny (CR19) 2014; 14 Relaix, Zammit (CR66) 2012; 13 Calić (CR32) 2006; 219 Collins (CR68) 2006; 6 Jun (CR74) 2008; 46 Willingham (CR3) 2000; 6 Soukup (CR30) 2011; 60 Chazaud (CR63) 2003; 163 Dhawan, Rando (CR69) 2005; 15 JT Litchfield (37837_CR75) 1949; 96 37837_CR5 37837_CR2 JD Jones (37837_CR47) 2014; 26 K Kuca (37837_CR13) 2007; 30 S Sorichter (37837_CR51) 1999; 5 V Pejchal (37837_CR44) 2008; 103 J Korabecny (37837_CR19) 2014; 14 O Soukup (37837_CR30) 2011; 60 R Sharma (37837_CR21) 2016; 259 O Soukup (37837_CR31) 2013; 87 37837_CR35 37837_CR37 L Nežić (37837_CR79) 2018; 8 M Moshiri (37837_CR48) 2017; 20 S Willingham (37837_CR3) 2000; 6 J Dhawan (37837_CR69) 2005; 15 TJ Bohlmeyer (37837_CR50) 1994; 20 M Calić (37837_CR32) 2006; 219 CH Dalton (37837_CR10) 2006; 20 Z Radic (37837_CR23) 2013; 203 D Swami (37837_CR38) 2016; 1 E Antonijevic (37837_CR34) 2016; 55 JE Chambers (37837_CR22) 2013; 203 Z Kovarik (37837_CR24) 2013; 203 B Chazaud (37837_CR62) 2014; 219 W Zhao (37837_CR61) 2016; 30 V Sepsova (37837_CR27) 2014; 14 J Bajgar (37837_CR7) 2004; 38 K Kuca (37837_CR71) 2003; 13 JG Tidball (37837_CR55) 1995; 27 H Toumi (37837_CR56) 2003; 37 JG Tidball (37837_CR57) 2007; 578 EL Andrade (37837_CR36) 2016; 49 DR Lemos (37837_CR65) 2015; 21 SW Wiener (37837_CR6) 2004; 19 JG Tidball (37837_CR54) 2005; 288 O Soukup (37837_CR29) 2010; 64 D Jun (37837_CR73) 2007; 40 V Jaćević (37837_CR78) 2018; 19 L Bartosova (37837_CR33) 2006; 9 R Sambasivan (37837_CR67) 2011; 138 T Laumonier (37837_CR52) 2016; 3 DE Lorke (37837_CR16) 2009; 29 P Masson (37837_CR9) 2011; 206 U Spöhrer (37837_CR17) 1994; 68 RH Adamson (37837_CR39) 2016; 80 K Kuca (37837_CR72) 2005; 25 P Munoz-Canoves (37837_CR64) 2015; 26 M Jokanovic (37837_CR11) 2009; 190 S Žunec (37837_CR43) 2015; 66 S Garattini (37837_CR26) 2014; 10 JG Tidball (37837_CR53) 2011; 1 V Jaćević (37837_CR76) 2016; 14 E Nepovimova (37837_CR20) 2016; 5 CA Collins (37837_CR68) 2006; 6 MC de Koning (37837_CR25) 2011; 206 IS McLennan (37837_CR59) 1996; 188 K Sakurada (37837_CR15) 2003; 28 JD Vassallo (37837_CR45) 2009; 111 B Chazaud (37837_CR63) 2003; 163 K Musilek (37837_CR40) 2007; 50 V Jaćević (37837_CR77) 2017; 102 JW Schlager (37837_CR18) 1991; 8 JG Tidball (37837_CR58) 2015; 23 F Relaix (37837_CR66) 2012; 13 K Kuca (37837_CR70) 2003; 44 L Szinicz (37837_CR1) 2005; 214 37837_CR46 DE Lorke (37837_CR28) 2007; 27 37837_CR49 L Gorecki (37837_CR14) 2016; 90 L Arnold (37837_CR60) 2007; 204 M Jokanovic (37837_CR12) 2012; 12 Y Wang (37837_CR41) 2015; 71 K Kuča (37837_CR42) 2018; 19 D Jun (37837_CR74) 2008; 46 J Bajgar (37837_CR8) 2009; 16 B Antonijevic (37837_CR4) 2007; 5 |
References_xml | – volume: 21 start-page: 786 year: 2015 end-page: 794 ident: CR65 article-title: Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis fibro/adipogenic progenitors publication-title: Nat. Med. doi: 10.1038/nm.3869 – volume: 60 start-page: 679 year: 2011 end-page: 686 ident: CR30 article-title: Oxime reactivators and their and effects on nicotinic receptors publication-title: Physiol. Res. – ident: CR49 – volume: 13 start-page: 3545 year: 2003 end-page: 3547 ident: CR71 article-title: Synthesis of a new reactivator of tabun-inhibited acetylcholinesterase publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(03)00751-0 – volume: 578 start-page: 327 year: 2007 end-page: 336 ident: CR57 article-title: Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice publication-title: J. Physiol. doi: 10.1113/jphysiol.2006.118265 – volume: 259 start-page: 85 year: 2016 end-page: 92 ident: CR21 article-title: Synthesis and reactivation screening of imidazolium and oximes as reactivators of sarin and VX-inhibited human acetylcholinesterase (hAChE) publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2016.04.034 – volume: 96 start-page: 99 year: 1949 end-page: 113 ident: CR75 article-title: A simplified method of evaluating dose-effect experiments publication-title: J. Pharmacol. Exp. Ther. – volume: 20 start-page: 845 year: 1994 end-page: 856 ident: CR50 article-title: Evaluation of laboratory tests as a guide to diagnosis and therapy of myositis publication-title: Rheum. Dis.Clin. North Am. – volume: 6 start-page: 301 year: 2006 end-page: 306 ident: CR68 article-title: Satellite cell self-renewal publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2006.01.006 – volume: 5 start-page: 1012 year: 2016 end-page: 1016 ident: CR20 article-title: A 7-methoxytacrine-4-pyridinealdoxime hybrid as a novel prophylactic agent with reactivation properties in organophosphate intoxication publication-title: Toxicol. Res. doi: 10.1039/C6TX00130K – volume: 16 start-page: 2977 year: 2009 end-page: 2986 ident: CR8 article-title: Chemical aspects of pharmacological prophylaxis against nerve agent poisoning publication-title: Curr. Med. Chem. doi: 10.2174/092986709788803088 – volume: 20 start-page: 256 year: 2017 end-page: 259 ident: CR48 article-title: Injury to skeletal muscle of mice following acute and sub-acute pregabalin exposure publication-title: Iran. J. Basic Med. Sci. – volume: 206 start-page: 54 year: 2011 end-page: 59 ident: CR25 article-title: Peripheral site ligand conjugation to a non-quaternary oxime enhances reactivation of nerve agent-inhibited human acetylcholinesterase publication-title: Toxicol Lett. doi: 10.1016/j.toxlet.2011.04.004 – volume: 71 start-page: 205 year: 2015 end-page: 212 ident: CR41 article-title: Relationship between lethal toxicity in oral administration and injection to mice: Effect of exposure routes publication-title: Reg. Toxicol. Pharma. doi: 10.1016/j.yrtph.2014.12.019 – volume: 103 start-page: 119 year: 2008 end-page: 123 ident: CR44 article-title: The Influence of Acetylcholinesterase Reactivators on Selected Hepatic Functions in Rats publication-title: Basic Clinic. Pharmacol. Toxicol. doi: 10.1111/j.1742-7843.2008.00249.x – ident: CR35 – volume: 30 start-page: 31 year: 2007 end-page: 40 ident: CR13 article-title: Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity publication-title: Drug Chem. Toxicol. doi: 10.1080/01480540601017637 – volume: 219 start-page: 172 year: 2014 end-page: 178 ident: CR62 article-title: Macrophages: supportive cells for tissue repair andregeneration publication-title: Immunobiol. doi: 10.1016/j.imbio.2013.09.001 – volume: 15 start-page: 666 year: 2005 end-page: 673 ident: CR69 article-title: Stem cells in postnatal myogenesis: molecularmechanisms of satellite cell quiescence, activation and replenishment publication-title: Trends Cell. Biol. doi: 10.1016/j.tcb.2005.10.007 – volume: 19 start-page: 2 year: 2018 end-page: 10 ident: CR42 article-title: A newly developed oxime K203 is the most effective reactivator of tabun-inhibited acetylcholinesterase publication-title: BC Pharmacol. Toxicol. doi: 10.1186/s40360-017-0193-y – volume: 49 start-page: e5646 year: 2016 ident: CR36 article-title: Non-clinical studies in the process of new dru development – Part II: Good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies publication-title: Braz. J. Med. Biol. Res. doi: 10.1590/1414-431X20165646 – volume: 19 start-page: 22 year: 2004 end-page: 37 ident: CR6 article-title: Nerve Agents: A Comprehensive publication-title: Review J. Intens. Care. Med. doi: 10.1177/0885066603258659 – volume: 214 start-page: 167 year: 2005 end-page: 81 ident: CR1 article-title: History of chemical and biological warfare agents publication-title: Toxicol. doi: 10.1016/j.tox.2005.06.011 – volume: 90 start-page: 2831 year: 2016 end-page: 2859 ident: CR14 article-title: SAR study to find optimal cholinesterase reactivator against organophosphorus nerve agents and pesticides publication-title: Arch. Toxicol. doi: 10.1007/s00204-016-1827-3 – volume: 38 start-page: 151 year: 2004 end-page: 216 ident: CR7 article-title: Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment publication-title: Adv. Clin. Chem. doi: 10.1016/S0065-2423(04)38006-6 – volume: 68 start-page: 480 year: 1994 end-page: 489 ident: CR17 article-title: Pharmacokinetics of the oximes HI 6 and HLö 7 in a dog after i.m. injection with newly developed dry/wet autoinjectors publication-title: Arch. Toxicol. doi: 10.1007/s002040050100 – ident: CR46 – volume: 37 start-page: 284 year: 2003 end-page: 286 ident: CR56 article-title: The inflammatory response: friend or enemy for muscle injury? publication-title: Br. J. Sports Med. doi: 10.1136/bjsm.37.4.284 – volume: 8 year: 2018 ident: CR79 article-title: Simvastatin protects cardiomyocytes against endotoxin-induced apoptosis and up-regulates survivin/NF-κB/p65 expression publication-title: Sci. Rep. doi: 10.1038/s41598-018-32376-4 – volume: 30 start-page: 380 year: 2016 end-page: 393 ident: CR61 article-title: CX3CR1 deficiency delays acute skeletal muscle injury repair by impairing macrophage functions publication-title: FASEB J doi: 10.1096/fj.14-270090 – volume: 203 start-page: 77 year: 2013 end-page: 80 ident: CR24 article-title: Centrally acting oximes in reactivation of tabun-phosphoramidite AChE publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.08.019 – volume: 29 start-page: 459 year: 2009 end-page: 469 ident: CR16 article-title: Minireview: does testing of oximes help predict their action after paraoxon exposure? publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1457 – volume: 9 start-page: 291 year: 2006 end-page: 296 ident: CR33 article-title: The acute toxicity of acetylcholinesterase reactivators in mice in relation to their structure publication-title: Neurotox. Res. doi: 10.1007/BF03033319 – volume: 66 start-page: 129 year: 2015 end-page: 134 ident: CR43 article-title: Comparative determination of the efficacy of bispyridinium oximes in paraoxon poisoning publication-title: Arh. Hig. Rada Toksikol. doi: 10.1515/aiht-2015-66-2623 – volume: 55 start-page: 33 year: 2016 end-page: 39 ident: CR34 article-title: Therapeutic and reactivating efficacy of oximes K027 and K203 against a direct acetylcholinesterase inhibitor publication-title: Neurotoxicol. doi: 10.1016/j.neuro.2016.05.006 – volume: 5 start-page: 71 year: 2007 end-page: 82 ident: CR4 article-title: Unequal efficacy of pyridinium oximes in acute organophosphate poisoning publication-title: Clinic. Med. Res. doi: 10.3121/cmr.2007.701 – volume: 14 start-page: 285 year: 2016 end-page: 297 ident: CR76 article-title: Effects of fullerenol nanoparticles and amifostine on radiation-induced tissue damages: Histopathological analysis publication-title: J. Appl. Biomed. doi: 10.1016/j.jab.2016.05.004 – ident: CR5 – volume: 206 start-page: 5 year: 2011 end-page: 13 ident: CR9 article-title: Evolution of and perspectives on therapeutic approaches to nerve agent poisoning publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2011.04.006 – volume: 203 start-page: 67 year: 2013 end-page: 71 ident: CR23 article-title: Mechanism of interaction of novel uncharged, centrally active reactivators with OP-hAChE conjugates publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.08.014 – volume: 19 start-page: 2370 year: 2018 ident: CR78 article-title: The efficacy of amifostine against multiple-dose doxorubicin-induced toxicity in rats publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19082370 – volume: 26 start-page: 697 year: 2014 end-page: 703 ident: CR47 article-title: The causes of drug-induced muscle toxicity publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0000000000000108 – volume: 13 start-page: 2845 year: 2012 end-page: 2856 ident: CR66 article-title: Satellite cells are essential for skeletal muscle regeneration: the cell on the edge returns to centre stage publication-title: Develop. doi: 10.1242/dev.069088 – volume: 28 start-page: 1401 year: 2003 end-page: 1407 ident: CR15 article-title: Pralidoximeiodide (2-pAM) penetrates across the blood-brain barrier publication-title: Neurochem. Res. doi: 10.1023/A:1024960819430 – volume: 190 start-page: 107 year: 2009 end-page: 115 ident: CR11 article-title: Medical treatment of acute poisoning with organophosphorus and carbamate pesticides publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2009.07.025 – volume: 12 start-page: 1775 year: 2012 end-page: 1789 ident: CR12 article-title: Structure-activity relationship and efficacy of pyridinium oximes in the treatment of poisoning with organophosphorus compounds: a review of recent data publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026611209061775 – volume: 26 start-page: 449 year: 2015 end-page: 450 ident: CR64 article-title: Macrophages decide between regenerationand fibrosis in muscle publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2015.07.005 – volume: 288 start-page: R345 year: 2005 end-page: R353 ident: CR54 article-title: Inflammatory processes in muscle injury and repair publication-title: Am. J.Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00454.2004 – volume: 6 start-page: 1 year: 2000 end-page: 7 ident: CR3 article-title: Military Role in U.S. Response to Terrorism Remains Unclear publication-title: Nat. Def. Mag. – volume: 25 start-page: 491 year: 2005 end-page: 495 ident: CR72 article-title: Effective bisquaternary reactivators of tabun-inhibited AChE publication-title: J. Appl Toxicol. doi: 10.1002/jat.1084 – ident: CR2 – ident: CR37 – volume: 44 start-page: 3123 year: 2003 end-page: 3125 ident: CR70 article-title: Synthesis of a potential reactivator of acetylcholinesterase-1-(4-hydroxyiminomethylpyridinium)-3-(carbamoylpyridinium)propane dibromide publication-title: Tetrahed. Lett. doi: 10.1016/S0040-4039(03)00538-0 – volume: 102 start-page: 360 year: 2017 end-page: 369 ident: CR77 article-title: Fullerenol nanoparticles prevent doxorubicin-induced acute hepatotoxicity in rats publication-title: Exp. Mol. Path. doi: 10.1016/j.yexmp.2017.03.005 – volume: 219 start-page: 85 year: 2006 end-page: 96 ident: CR32 article-title: and evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, the effect on tabun- and soman-poisoned mice and their cytotoxicity publication-title: Toxicol. doi: 10.1016/j.tox.2005.11.003 – volume: 50 start-page: 5514 year: 2007 end-page: 5548 ident: CR40 article-title: Design of a potent reactivator of tabun-inhibited acetylcholinesterase-synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203) publication-title: J. Med. Chem. doi: 10.1021/jm070653r – volume: 20 start-page: 1532 year: 2006 end-page: 1536 ident: CR10 article-title: Absorption of the nerve agent VX (O-ethyl-S-[2(di-isopropylamino)ethyl] methylphosphonothioate)through the pig, human and guinea pig skin publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2006.06.009 – volume: 64 start-page: 541 year: 2010 end-page: 545 ident: CR29 article-title: Novel acetylcholinesterase reactivator K112 and its cholinergic properties publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2010.01.002 – volume: 204 start-page: 1057 year: 2007 end-page: 1069 ident: CR60 article-title: Inflammatory monocytes recruited after skeletal muscle injury switch into antiinflammatory macrophages to support myogenesis publication-title: J. Exp. Med. doi: 10.1084/jem.20070075 – volume: 14 start-page: 16882 year: 2014 end-page: 16900 ident: CR27 article-title: Oximes: inhibitors of human recombinant acetylcholinesterase. A structure-activity relationship (SAR) study publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms140816882 – volume: 23 start-page: 1134 year: 2015 end-page: 1135 ident: CR58 article-title: Macrophage-derived IGF-1 is a potent coordinator of myogenesis and inflammation in regenerating muscle publication-title: Mol. Ther. doi: 10.1038/mt.2015.97 – volume: 80 start-page: 274 year: 2016 end-page: 276 ident: CR39 article-title: The acute lethal dose 50 (LD ) of caffeine in albino rats publication-title: Reg. Toxicol. Pharmacol. doi: 10.1016/j.yrtph.2016.07.011 – volume: 27 start-page: 482 year: 2007 end-page: 490 ident: CR28 article-title: Entry of two new asymmetric bispyridinium oximes (K-27 and K-48) into the rat brain: comparison with obidoxime publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1229 – volume: 3 start-page: 1 year: 2016 end-page: 9 ident: CR52 article-title: Muscle injuries and strategies for improving their repair publication-title: J. Exp. Orthop. doi: 10.1186/s40634-016-0051-7 – volume: 14 start-page: 215 year: 2014 end-page: 221 ident: CR19 article-title: From pyridinium-based to centrally active acetylcholinesterase reactivators publication-title: Mini. Rev. Med. Chem. doi: 10.2174/1389557514666140219103138 – volume: 188 start-page: 17 year: 1996 end-page: 28 ident: CR59 article-title: Degenerating and regenerating skeletal muscles contain several subpopulations of macrophages with distinct spatial and temporal distributions publication-title: J. Anat. – volume: 27 start-page: 1022 year: 1995 end-page: 1032 ident: CR55 article-title: Inflammatory cell response to acute muscle injury publication-title: Med. Sci. Sports Exerc. doi: 10.1249/00005768-199507000-00011 – volume: 46 start-page: 316 year: 2008 end-page: 319 ident: CR74 article-title: TLC Analysis of intermediates arising during the preparation of oxime HI-6 dimethanesulfonate publication-title: J. Chromat. Sci. doi: 10.1093/chromsci/46.4.316 – volume: 1 start-page: 149 year: 2016 end-page: 154 ident: CR38 article-title: Comparative toxicity of pyridinium acetamide derivatives in human cell lines and their acute toxicity in Swiss albino mice publication-title: Def. Life Sci. J. doi: 10.14429/dlsj.1.10733 – volume: 203 start-page: 135 year: 2013 end-page: 138 ident: CR22 article-title: Testing of novel brain-penetrating oxime reactivators of acetylcholinesterase inhibited by nerve agent surrogates publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.10.017 – volume: 111 start-page: 402 year: 2009 end-page: 412 ident: CR45 article-title: Biomarkers of drug-induced skeletal muscle injury in the rat: troponin I and myoglobin publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfp166 – volume: 10 start-page: 602 year: 2014 end-page: 610 ident: CR26 article-title: Drug development: how academia, industry and authorities interact publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2014.133 – volume: 163 start-page: 1133 year: 2003 end-page: 1143 ident: CR63 article-title: Satellite cells attract monocytes and usemacrophages as a support to escape apoptosis and enhance muscle growth publication-title: J. Cell. Biol. doi: 10.1083/jcb.200212046 – volume: 138 start-page: 3647 year: 2011 end-page: 3656 ident: CR67 article-title: Pax7-expressing satellitecells are indispensable for adult skeletal muscle regeneration publication-title: Develop. doi: 10.1242/dev.067587 – volume: 87 start-page: 711 year: 2013 end-page: 719 ident: CR31 article-title: The summary on non-reactivation cholinergic properties of oxime reactivators: the interaction with muscarinic and nicotinic receptors publication-title: Arch Toxicol. doi: 10.1007/s00204-012-0977-1 – volume: 5 start-page: 5 year: 1999 end-page: 21 ident: CR51 article-title: Skeletal muscle injury induced by eccentric muscle action: Muscle proteins as markers of muscle fibre injury publication-title: Exerc. Immunol. Rev. – volume: 40 start-page: 2783 year: 2007 end-page: 2787 ident: CR73 article-title: HPLC analysis of HI‐6 dichloride and dimethanesulfonate-antidotes against nerve agents and organophosphorus pesticides publication-title: Analyt. Lett. doi: 10.1080/00032710701588531 – volume: 1 start-page: 2029 year: 2011 end-page: 2062 ident: CR53 article-title: Mechanisms of muscle injury, repair, and regeneration publication-title: Compr. Physiol. – volume: 8 start-page: 1191 year: 1991 end-page: 1194 ident: CR18 article-title: Operation evaluation of three commercial configurations of atropine/HI-6 wet/dry autoinjectors publication-title: Pharm. Res. doi: 10.1023/A:1015818821686 – volume: 20 start-page: 845 year: 1994 ident: 37837_CR50 publication-title: Rheum. Dis.Clin. North Am. doi: 10.1016/S0889-857X(21)00069-7 – volume: 68 start-page: 480 year: 1994 ident: 37837_CR17 publication-title: Arch. Toxicol. doi: 10.1007/s002040050100 – volume: 12 start-page: 1775 year: 2012 ident: 37837_CR12 publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026611209061775 – volume: 16 start-page: 2977 year: 2009 ident: 37837_CR8 publication-title: Curr. Med. Chem. doi: 10.2174/092986709788803088 – ident: 37837_CR49 – volume: 5 start-page: 5 year: 1999 ident: 37837_CR51 publication-title: Exerc. Immunol. Rev. – volume: 25 start-page: 491 year: 2005 ident: 37837_CR72 publication-title: J. Appl Toxicol. doi: 10.1002/jat.1084 – volume: 26 start-page: 697 year: 2014 ident: 37837_CR47 publication-title: Curr. Opin. Rheumatol. doi: 10.1097/BOR.0000000000000108 – volume: 6 start-page: 301 year: 2006 ident: 37837_CR68 publication-title: Curr. Opin. Pharmacol. doi: 10.1016/j.coph.2006.01.006 – volume: 6 start-page: 1 year: 2000 ident: 37837_CR3 publication-title: Nat. Def. Mag. – volume: 49 start-page: e5646 year: 2016 ident: 37837_CR36 publication-title: Braz. J. Med. Biol. Res. doi: 10.1590/1414-431X20165646 – volume: 20 start-page: 1532 year: 2006 ident: 37837_CR10 publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2006.06.009 – ident: 37837_CR35 – volume: 1 start-page: 149 year: 2016 ident: 37837_CR38 publication-title: Def. Life Sci. J. doi: 10.14429/dlsj.1.10733 – volume: 5 start-page: 71 year: 2007 ident: 37837_CR4 publication-title: Clinic. Med. Res. doi: 10.3121/cmr.2007.701 – volume: 29 start-page: 459 year: 2009 ident: 37837_CR16 publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1457 – volume: 55 start-page: 33 year: 2016 ident: 37837_CR34 publication-title: Neurotoxicol. doi: 10.1016/j.neuro.2016.05.006 – volume: 71 start-page: 205 year: 2015 ident: 37837_CR41 publication-title: Reg. Toxicol. Pharma. doi: 10.1016/j.yrtph.2014.12.019 – volume: 138 start-page: 3647 year: 2011 ident: 37837_CR67 publication-title: Develop. doi: 10.1242/dev.067587 – volume: 1 start-page: 2029 year: 2011 ident: 37837_CR53 publication-title: Compr. Physiol. doi: 10.1002/cphy.c100092 – volume: 163 start-page: 1133 year: 2003 ident: 37837_CR63 publication-title: J. Cell. Biol. doi: 10.1083/jcb.200212046 – volume: 204 start-page: 1057 year: 2007 ident: 37837_CR60 publication-title: J. Exp. Med. doi: 10.1084/jem.20070075 – volume: 30 start-page: 380 year: 2016 ident: 37837_CR61 publication-title: FASEB J doi: 10.1096/fj.14-270090 – volume: 9 start-page: 291 year: 2006 ident: 37837_CR33 publication-title: Neurotox. Res. doi: 10.1007/BF03033319 – volume: 37 start-page: 284 year: 2003 ident: 37837_CR56 publication-title: Br. J. Sports Med. doi: 10.1136/bjsm.37.4.284 – volume: 203 start-page: 135 year: 2013 ident: 37837_CR22 publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.10.017 – volume: 203 start-page: 67 year: 2013 ident: 37837_CR23 publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.08.014 – volume: 80 start-page: 274 year: 2016 ident: 37837_CR39 publication-title: Reg. Toxicol. Pharmacol. doi: 10.1016/j.yrtph.2016.07.011 – volume: 23 start-page: 1134 year: 2015 ident: 37837_CR58 publication-title: Mol. Ther. doi: 10.1038/mt.2015.97 – volume: 259 start-page: 85 year: 2016 ident: 37837_CR21 publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2016.04.034 – volume: 103 start-page: 119 year: 2008 ident: 37837_CR44 publication-title: Basic Clinic. Pharmacol. Toxicol. doi: 10.1111/j.1742-7843.2008.00249.x – volume: 13 start-page: 2845 year: 2012 ident: 37837_CR66 publication-title: Develop. doi: 10.1242/dev.069088 – volume: 50 start-page: 5514 year: 2007 ident: 37837_CR40 publication-title: J. Med. Chem. doi: 10.1021/jm070653r – volume: 188 start-page: 17 year: 1996 ident: 37837_CR59 publication-title: J. Anat. – volume: 30 start-page: 31 year: 2007 ident: 37837_CR13 publication-title: Drug Chem. Toxicol. doi: 10.1080/01480540601017637 – ident: 37837_CR2 – volume: 87 start-page: 711 year: 2013 ident: 37837_CR31 publication-title: Arch Toxicol. doi: 10.1007/s00204-012-0977-1 – volume: 96 start-page: 99 year: 1949 ident: 37837_CR75 publication-title: J. Pharmacol. Exp. Ther. – volume: 60 start-page: 679 year: 2011 ident: 37837_CR30 publication-title: Physiol. Res. doi: 10.33549/physiolres.932105 – ident: 37837_CR5 doi: 10.21236/ADA398241 – volume: 214 start-page: 167 year: 2005 ident: 37837_CR1 publication-title: Toxicol. doi: 10.1016/j.tox.2005.06.011 – volume: 46 start-page: 316 year: 2008 ident: 37837_CR74 publication-title: J. Chromat. Sci. doi: 10.1093/chromsci/46.4.316 – volume: 3 start-page: 1 year: 2016 ident: 37837_CR52 publication-title: J. Exp. Orthop. doi: 10.1186/s40634-016-0051-7 – volume: 288 start-page: R345 year: 2005 ident: 37837_CR54 publication-title: Am. J.Physiol. Regul. Integr. Comp. Physiol. doi: 10.1152/ajpregu.00454.2004 – ident: 37837_CR46 doi: 10.1007/978-3-0348-8958-2_19 – volume: 203 start-page: 77 year: 2013 ident: 37837_CR24 publication-title: Chem. Biol. Interact. doi: 10.1016/j.cbi.2012.08.019 – volume: 14 start-page: 215 year: 2014 ident: 37837_CR19 publication-title: Mini. Rev. Med. Chem. doi: 10.2174/1389557514666140219103138 – volume: 66 start-page: 129 year: 2015 ident: 37837_CR43 publication-title: Arh. Hig. Rada Toksikol. doi: 10.1515/aiht-2015-66-2623 – volume: 111 start-page: 402 year: 2009 ident: 37837_CR45 publication-title: Toxicol. Sci. doi: 10.1093/toxsci/kfp166 – volume: 90 start-page: 2831 year: 2016 ident: 37837_CR14 publication-title: Arch. Toxicol. doi: 10.1007/s00204-016-1827-3 – volume: 13 start-page: 3545 year: 2003 ident: 37837_CR71 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/S0960-894X(03)00751-0 – volume: 10 start-page: 602 year: 2014 ident: 37837_CR26 publication-title: Nat. Rev. Nephrol. doi: 10.1038/nrneph.2014.133 – ident: 37837_CR37 – volume: 14 start-page: 16882 year: 2014 ident: 37837_CR27 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms140816882 – volume: 27 start-page: 482 year: 2007 ident: 37837_CR28 publication-title: J. Appl. Toxicol. doi: 10.1002/jat.1229 – volume: 190 start-page: 107 year: 2009 ident: 37837_CR11 publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2009.07.025 – volume: 40 start-page: 2783 year: 2007 ident: 37837_CR73 publication-title: Analyt. Lett. doi: 10.1080/00032710701588531 – volume: 26 start-page: 449 year: 2015 ident: 37837_CR64 publication-title: Trends Endocrinol. Metab. doi: 10.1016/j.tem.2015.07.005 – volume: 219 start-page: 172 year: 2014 ident: 37837_CR62 publication-title: Immunobiol. doi: 10.1016/j.imbio.2013.09.001 – volume: 27 start-page: 1022 year: 1995 ident: 37837_CR55 publication-title: Med. Sci. Sports Exerc. doi: 10.1249/00005768-199507000-00011 – volume: 21 start-page: 786 year: 2015 ident: 37837_CR65 publication-title: Nat. Med. doi: 10.1038/nm.3869 – volume: 64 start-page: 541 year: 2010 ident: 37837_CR29 publication-title: Biomed. Pharmacother. doi: 10.1016/j.biopha.2010.01.002 – volume: 20 start-page: 256 year: 2017 ident: 37837_CR48 publication-title: Iran. J. Basic Med. Sci. – volume: 8 year: 2018 ident: 37837_CR79 publication-title: Sci. Rep. doi: 10.1038/s41598-018-32376-4 – volume: 19 start-page: 2370 year: 2018 ident: 37837_CR78 publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19082370 – volume: 206 start-page: 54 year: 2011 ident: 37837_CR25 publication-title: Toxicol Lett. doi: 10.1016/j.toxlet.2011.04.004 – volume: 5 start-page: 1012 year: 2016 ident: 37837_CR20 publication-title: Toxicol. Res. doi: 10.1039/C6TX00130K – volume: 44 start-page: 3123 year: 2003 ident: 37837_CR70 publication-title: Tetrahed. Lett. doi: 10.1016/S0040-4039(03)00538-0 – volume: 102 start-page: 360 year: 2017 ident: 37837_CR77 publication-title: Exp. Mol. Path. doi: 10.1016/j.yexmp.2017.03.005 – volume: 19 start-page: 22 year: 2004 ident: 37837_CR6 publication-title: Review J. Intens. Care. Med. doi: 10.1177/0885066603258659 – volume: 28 start-page: 1401 year: 2003 ident: 37837_CR15 publication-title: Neurochem. Res. doi: 10.1023/A:1024960819430 – volume: 15 start-page: 666 year: 2005 ident: 37837_CR69 publication-title: Trends Cell. Biol. doi: 10.1016/j.tcb.2005.10.007 – volume: 38 start-page: 151 year: 2004 ident: 37837_CR7 publication-title: Adv. Clin. Chem. doi: 10.1016/S0065-2423(04)38006-6 – volume: 19 start-page: 2 year: 2018 ident: 37837_CR42 publication-title: BC Pharmacol. Toxicol. doi: 10.1186/s40360-017-0193-y – volume: 206 start-page: 5 year: 2011 ident: 37837_CR9 publication-title: Toxicol. Lett. doi: 10.1016/j.toxlet.2011.04.006 – volume: 219 start-page: 85 year: 2006 ident: 37837_CR32 publication-title: Toxicol. doi: 10.1016/j.tox.2005.11.003 – volume: 578 start-page: 327 year: 2007 ident: 37837_CR57 publication-title: J. Physiol. doi: 10.1113/jphysiol.2006.118265 – volume: 8 start-page: 1191 year: 1991 ident: 37837_CR18 publication-title: Pharm. Res. doi: 10.1023/A:1015818821686 – volume: 14 start-page: 285 year: 2016 ident: 37837_CR76 publication-title: J. Appl. Biomed. doi: 10.1016/j.jab.2016.05.004 |
SSID | ssj0000529419 |
Score | 2.3572614 |
Snippet | Therapeutic application of newly developed oximes is limited due to their adverse effects on different tissues. Within this article, it has been investigated... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1457 |
SubjectTerms | 14/63 64/60 692/4017 692/499 Animal tissues Cholinesterase Degeneration Diaphragm Drug dosages Edema Humanities and Social Sciences Morphology Mortality multidisciplinary Muscles Obidoxime Oximes Poisoning Science Science (multidisciplinary) Toxicity |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEBZNQiGX0KQvNw8U6K0VsWxZj1MJZZe0kAbKBvZm9KQJxd7WXrL99xnZXodtSM4aIWs-j2Y0o5lB6COoVJO7IiWBSk9YkAVRmaakoIJaaRhPXXQNXP7gF9fs-7yYDw63ZnhWuT4Tu4Pa1Tb6yM_AdOYidlVJvyz-kNg1KkZXhxYaW2iHgiUSWzeIuRh9LDGKxagacmXSXJ41oK9iThmVIFlwNyNsUx89MjIfv5X8L2Da6aHpK7Q3GJD4vEd8H73w1QF62beU_PcaTWb16sbib9UtMAu3Nb5cNkCHZx2DcR3wT902eArw13ewAD63y9bjq1VMBcGT1aKOLsM36Ho6mX29IEOrBGKZYC3JnQnaKJbBRVkY7wVYGSC6usi85dQUqSmUya22yikTBANklOHeS2czKzXP36Ltqq78e4S1C95wboWHq1kWmMmkC4FRp41XRqgE0TXDSjvUEY_tLH6XXTw7l2XP5BKYXHZMLlmCPo1zFn0VjWepj9Y4lINENeUD_gk6HYdBFmKAQ1e-XgJNLF4fU2dlgt71sI3LwVkGmjiD2WID0JEg1tneHKlufnX1tnnOY526BH1eQ__wWU_v4sPzuzhEu2B7qe4BOD9C2-3fpT8G-6Y1J91PfA8LGfhn priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3daxQxEB9qRehLsdXW1VYi-KaLm91sPh5LuaMWqiBX6NuSZBNakd3S28Pzv3eS_ZCzteDzTkh2JsnMZGZ-A_AeVaop6jJLPZUuZV6Wqco1TUsqqJWG8awOTwMXX_jZJTu_Kq-2IB9rYWLSfoS0jNf0mB32aYmKJhSDUYlHAp2qlD2Bp1KgtgwBWn46vauEyBWjaqiPyQr5wNBNHXTPsLyfH_lXkDTqnvlz2B2MRnLSL3MPtlyzD8_6NpK_XsBs0a5vLPncfEcGka4lF6sl0pFFZCppPfmmuyWZo8jbnzgBObGrzpGv61D-QWbr2zY8E76Ey_lscXqWDu0RUssE69KiNl4bxXJ0joVxTqBlgcdVl7mznJoyM6UyhdVW1cp4wVAaynDnZG1zKzUvDmC7aRv3CoiuvTOcW-HQHcs9M7msvWe01sYpI1QCdGRYZQfs8NDC4kcVY9iFrHomV8jkKjK5Ygl8mMbc9sgZj1IfjXKohlO0rNBd4iJ00skSeDd9xv0fghq6ce0KaQJgfSiXlQkc9mKbpsP7C7VvjqPFhkAngoCtvfmlubmOGNu84AGbLoGPo-j_LOvff_H6_8jfwA7aXyomgfMj2O7uVu4YbZzOvI2b-jcg9fZe priority: 102 providerName: Springer Nature |
Title | Toxic Injury to Muscle Tissue of Rats Following Acute Oximes Exposure |
URI | https://link.springer.com/article/10.1038/s41598-018-37837-4 https://www.ncbi.nlm.nih.gov/pubmed/30728420 https://www.proquest.com/docview/2176706730 https://www.proquest.com/docview/2229078118 https://pubmed.ncbi.nlm.nih.gov/PMC6365527 |
Volume | 9 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw8LQPgfaCxucyRmUk3iBQJ44_HhDqqlaj0gYardS3KHYcsWlKtjUV3b_n7CSFsY2nSPFZdu4jd-fz3QG8Q5Wq4zzphwWVNmSFTEIVZTRMqKBGasb7uTsaOD7hRzM2mSfzDejaHbUIXNzr2rl-UrPri4-rq5svKPCfm5Rx-WmBSsglilGJ4oIOV8g2YdvHi9xVvtbcb2p9R4pR1ebO3D91Bx4j2-NP23UA_1tV3bE_716j_CeW6lXUeBeetLYlGTTM8BQ2bPkMHjXdJm-ew2harc4M-VqeIx5JXZHj5QLhyNTjnlQFOc3qBRkjZ1S_cAEyMMvakm8rlyVCRqvLyp0mvoDZeDQdHoVtF4XQMMHqMM51kWnFIvShhbZWoAGCUp0lkTWc6qSvE6VjkxmVK10IhkRTmlsrcxMZmfH4JWyVVWn3gGR5YTXnRlj02qKC6UjmRcFonmmrtFAB0A5hqWlLjLtOFxepD3XHMm3wnSK-U4_vlAXwfj3nsimw8V_og44OaccrKXpVXLiGO_0A3q6HUUxc7CMrbbVEGFfX3mXVygBeNWRbL9fROwBxi6BrAFeC-_ZIefbTl-LmMXcl7AL40JH-z7Ye_or9B7fwGnbQIlP-Wjg_gK36emnfoNVT6x5sirnowfZgMPkxwefh6OT7Kb4d8mHPnyT0PLP_BgHlAWE |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFS2QnBBvAkUMBKcIGoejmMfKlRgV7u0u6BqK_UW_IooQslCsur25_g2xnlstVT01rPHcTwPz3jGMwPwGlWqik0S-HnIrU9znvgikqGfhGmouaIsMM41MJ2x8TH9fJKcbMGfPhfGPavsz8TmoDaldj7yXTSdWeq6qgTvF7981zXKRVf7Fhqya61g9poSY11ix4E9P8MrXLU3-YT0fhNFo-H849jvugz4mqa09mOjcqkEjfCOmSprU1TQyPUyiaxmoUoClQgVa6mFESpPKW5KKGYtNzrSXLIYv3sDtqlzoAxg-8Nw9vVo7eVxcTQaii5bJ4j5boUa02W1hRxlG2-HPt3UiJfM3MuvNf8J2TaacHQX7nQmLNlvee4ebNniPtxsm1qeP4DhvFydajIpfiC5SF2S6bJCODJvSEzKnBzJuiIjZMDyDBcg-3pZW_Jl5ZJRyHC1KJ3T8iEcXwsaH8GgKAv7BIg0uVWM6dTi5TDKqYq4yXMaGqmsUKnwIOwRlumukrlrqPEzayLqMc9aJGeI5KxBckY9eLues2jreFwJvdPTIetkusouONCDV-thlEYXYpGFLZcI48rnu-Rd7sHjlmzr5fA0RVsgwtnpBkHXAK7S9-ZIcfq9qfjNYuYq5Xnwrif9xW_9fxdPr97FS7g1nk8Ps8PJ7OAZ3EZLUDTP0dkODOrfS_scra1avehYmsC365aiv8fZPhA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3LbtQwcFSKQFwQb1JKMRKcINo8HD8OCFXtrrqUFoS20t5C7NiiCCVLk1W3v8bXMc6rWip669njOJ6HZ8bjmQF4gypVxXkS-DYUxqdWJL6MstBPQh5qoSgLcnc1cHTMDk7op3ky34A_fS6Me1bZn4nNQZ2X2t2Rj9B0Ztx1VQlGtnsW8XV_8nHx23cdpFyktW-n0bLIobk4R_et-jDdR1q_jaLJeLZ34HcdBnxNOa39OFc2U5JG6F9yZQxH5YwcnyWR0SxUSaASqWKdaZlLZTnFDUnFjBG5jrTIWIzfvQW3eUypaxvB53y433ERNBrKLk8niMWoQl3p8tlCgVKNfqFP13XhFQP36jvNf4K1jQ6cPID7nfFKdltuewgbpngEd9p2lhePYTwrV6eaTIufSChSl-RoWSEcmTXEJaUl37K6IhNkvfIcFyC7elkb8mXl0lDIeLUo3XXlEzi5ESQ-hc2iLMxzIFlujWJMc4NuYWSpikRuLQ3zTBmpuPQg7BGW6q6GuWul8SttYumxSFskp4jktEFySj14N8xZtBU8roXe7umQdtJcpZe858HrYRjl0AVXssKUS4RxhfNd2q7w4FlLtmE5PEfRCohwNl8j6ADganyvjxSnP5pa3yxmrkaeB-970l_-1v93sXX9Ll7BXZSd9PP0-PAF3EMTUDbv0Nk2bNZnS_MSzaxa7TT8TOD7TQvQXyOuO6w |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Toxic+Injury+to+Muscle+Tissue+of+Rats+Following+Acute+Oximes+Exposure&rft.jtitle=Scientific+reports&rft.au=Ja%C4%87evi%C4%87%2C+Vesna&rft.au=Nepovimova%2C+Eugenie&rft.au=Ku%C4%8Da%2C+Kamil&rft.date=2019-02-06&rft.eissn=2045-2322&rft.volume=9&rft.issue=1&rft.spage=1457&rft_id=info:doi/10.1038%2Fs41598-018-37837-4&rft_id=info%3Apmid%2F30728420&rft.externalDocID=30728420 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon |